Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Dec;21(4):287-90.
doi: 10.3904/kjim.2006.21.4.287.

Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock

Affiliations
Case Reports

Skin necrosis after a low-dose vasopressin infusion through a central venous catheter for treating septic shock

Eun Hee Kim et al. Korean J Intern Med. 2006 Dec.

Abstract

This is a report on a case of severe skin necrosis in a vasodilatory septic shock patient after the infusion of low-dose vasopressin through a central venous catheter. An 84-year-old male was hospitalized for edema on both legs at Asan Medical Center, Seoul, Korea. On hospital day 8, the patient began to complain of dyspnea and he subsequently developed severe septic shock caused by E. coli. After being transferred to the medical intensive care unit, his hypotension, which was refractory to norepinephrine, was controlled by an infusion of low-dose vasopressin (0.02 unit/min) through a central venous catheter into the right subclavian vein. After the infusion of low-dose vasopressin, severe skin necrosis with bullous changes developed, necessitating discontinuation of the low-dose vasopressin infusion. The patient expired from refractory septic shock. Although low-dose vasopressin can control hypotension in septic shock patients, low-dose vasopressin must be used with caution because ischemic complications such as skin necrosis can develop even with administration through a central venous catheter.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Skin necrosis in a vasodilatory septic shock patient treated with low-dose vasopressin. After the infusion, necrosis with variable sized bullous changes developed at both wrists and on both lower legs. In time, the skin lesions expanded to the both arms, both thighs and the abdomen.

References

    1. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004;30:1276–1291. - PubMed
    1. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313–2319. - PubMed
    1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Lery MM. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858–873. - PubMed
    1. Gimson AE, Westaby D, Hegarty J, Watson A, Willians R. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology. 1986;6:410–413. - PubMed
    1. Davison R, Kaplan K, Bines A, Spies S, Reed MT, Lesch M. Abnormality thallium 201 scintigraphy during low-dose vasopressin infusions. Chest. 1986;90:798–801. - PubMed

Publication types

MeSH terms

LinkOut - more resources